SIK2 inhibition enhances PARP inhibitor activity synergistically in ovarian and triple-negative breast cancers
SIK2 抑制可协同增强 PARP 抑制剂在卵巢癌和三阴性乳腺癌中的活性
期刊:Journal of Clinical Investigation
影响因子:13.3
doi:10.1172/JCI146471
Zhen Lu, Weiqun Mao, Hailing Yang, Janice M Santiago-O'Farrill, Philip J Rask, Jayanta Mondal, Hu Chen, Cristina Ivan, Xiuping Liu, Chang-Gong Liu, Yuanxin Xi, Kenta Masuda, Eli M Carrami, Meng Chen, Yitao Tang, Lan Pang, David S Lakomy, George A Calin, Han Liang, Ahmed A Ahmed, Hariprasad Vankayala